Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients

Microbiology

Volumn 156, Issue 7, 2010, Pages 2058-2067

  Bakkal, Suphan ^a   Robinson, Sandra M ^a   Ordonez, Claudia L ^b   Waltz, David A ^b   Riley, Margaret A ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; PYOCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA COMPLEX; CONTROLLED STUDY; CYSTIC FIBROSIS; LUNG; MOLECULAR INTERACTION; NONHUMAN; ORGANISMAL INTERACTION; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; BURKHOLDERIA INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PSEUDOMONAS INFECTION;

BACTERIOCINS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYOCINS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA COMPLEX; PSEUDOMONAS AERUGINOSA;

EID: 77954567217     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.036848-0     Document Type: Article

References (60)

1. Al-Bakri, A. G., Gilbert, P. & Allison, D. G. (2004). Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J Appl Microbiol 96, 455-463. (Pubitemid 38297067)
2. Blackwell, C. C., Young, H. & Anderson, I. (1979). Sensitivity of Neisseria gonorrhoeae to partially purified R-type pyocines and a possible approach to epidemiological typing. J Med Microbiol 12, 321-335. (Pubitemid 9254229)
3. Bouhaddioui, B., Ben Slama, K., Gharbi, S. & Boudabous, A. (2002). Epidemiology of clinical and environmental Pseudomonas aeruginosa strains. Ann Microbiol 52, 223-235. (Pubitemid 44844335)
4. Brazas, M. D. & Hancock, R. E. (2005). Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49, 3222-3227. (Pubitemid 41060565)
5. Chang, W., Small, D. A., Toghrol, F. & Bentley, W. E. (2005). Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide. BMC Genomics 6, 115. (Pubitemid 41372424)
6. Cystic Fibrosis Foundation (2007). Patient Registry 2007 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation.
7. de Chial, M., Ghysels, B., Beatson, S. A., Geoffroy, V., Meyer, J. M., Pattery, T., Baysse, C., Chablain, P., Parsons, Y. N. & other authors (2003). Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology 149, 821-831.
8. Denayer, S., Matthijs, S. & Cornelis, P. (2007). Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor. J Bacteriol 189, 7663-7668. (Pubitemid 350035076)
9. Diez-Gonzalez, F. (2007). Use of bacteriocins in livestock. In Research and Applications in Bacteriocins, pp. 117-129. Edited by M. A. Riley & O. Gillor. Norwich, UK: Horizon Bioscience.
10. Duport, C., Baysse, C. & Michel-Briand, Y. (1995). Molecular characterization of pyocin S3, a novel S-type pyocin from Pseudomonas aeruginosa. J Biol Chem 270, 8920-8927.
11. Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B. & Gibson, R. L. (2002). Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34, 91-100.
12. Farmer, J. J., III & Herman, L. G. (1969). Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage. Appl Microbiol 18, 760-765.
13. Filiatrault, M. J., Munson, R. S., Jr & Campagnari, A. A. (2001). Genetic analysis of a pyocin-resistant lipooligosaccharide (LOS) mutant of Haemophilus ducreyi: restoration of full-length LOS restores pyocin sensitivity. J Bacteriol 183, 5756-5761.
14. Fyfe, J. A., Harris, G. & Govan, J. R. (1984). Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol 20, 47-50.
15. Gibson, R. L., Burns, J. L. & Ramsey, B. W. (2003). Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168, 918-951.
16. Gillor, O., Nigro, L. M. & Riley, M. A. (2005). Genetically engineered bacteriocins and their potential as the next generation of antimicrobials. Curr Pharm Des 11, 1067-1075.
17. Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539-574.
18. Govan, J. R. & Harris, G. (1985). Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol 22, 490-494.
19. Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M. & Parsek, M. R. (2001). Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol 183, 5395-5401.
20. Heo, Y. J., Chung, I. Y., Choi, K. B. & Cho, Y. H. (2007). R-type pyocin is required for competitive growth advantage between Pseudomonas aeruginosa strains. J Microbiol Biotechnol 17, 180-185.
21. Huang, C. H., Jang, T. N., Liu, C. Y., Fung, C. P., Yu, K. W. & Wong, W. W. (2001). Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect 34, 215-219. (Pubitemid 32937656)
22. Ito, S., Kageyama, M. & Egami, F. (1970). Isolation and characterization of pyocins from several strains of Pseudomonas aeruginosa. J Gen Appl Microbiol 16, 205-214.
23. Jones, L. F., Zakanycz, J. P., Thomas, E. T. & Farmer, J. J., III (1974). Pyocin typing of Pseudomonas aeruginosa: a simplified method. Appl Microbiol 27, 400-406.
24. Jones, A. M., Dodd, M. E., Govan, J. R., Barcus, V., Doherty, C. J., Morris, J. & Webb, A. K. (2004). Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 59, 948-951. (Pubitemid 39490778)
25. Kageyama, M., Shinomiya, T., Aihara, Y. & Kobayashi, M. (1979). Characterization of a bacteriophage related to R-type pyocins. J Virol 32, 951-957. (Pubitemid 10168485)
26. Kalish, L. A., Waltz, D. A., Dovey, M., Potter-Bynoe, G., McAdam, A. J., Lipuma, J. J., Gerard, C. & Goldmann, D. (2006). Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med 173, 421-425. (Pubitemid 43228330)
27. Kerr, B., Riley, M. A., Feldman, M. W. & Bohannan, B. J. (2002). Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature 418, 171-174. (Pubitemid 34773769)
28. Kuroda, K. & Kageyama, M. (1981). Comparative study of F-type pyocins of Pseudomonas aeruginosa. J Biochem 89, 1721-1736. (Pubitemid 11048503)
29. Lambiase, A., Raia, V., Del Pezzo, M., Sepe, A., Carnovale, V. & Rossano, F. (2006). Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis 6, 4.
30. Langley, R., Kenna, D. T., Vandamme, P., Ure, R. & Govan, J. R. (2003). Lysogeny and bacteriophage host range within the Burkholderia cepacia complex. J Med Microbiol 52, 483-490.
31. Ledson, M. J., Gallagher, M. J., Corkill, J. E., Hart, C. A. & Walshaw, M. J. (1998). Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 53, 432-436.
32. Ledson, M. J., Gallagher, M. J., Jackson, M., Hart, C. A. & Walshaw, M. J. (2002). Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 57, 142-145.
33. Loutet, S. A., Flannagan, R. S., Kooi, C., Sokol, P. A. & Valvano, M. A. (2006). A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188, 2073-2080. (Pubitemid 43376461)
34. Matsui, H., Sano, Y., Ishihara, H. & Shinomiya, T. (1993). Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J Bacteriol 175, 1257-1263. (Pubitemid 23081799)
35. McKenney, D., Brown, K. E. & Allison, D. G. (1995). Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J Bacteriol 177, 6989-6992.
36. McManus, T. E., McDowell, A., Moore, J. E. & Elborn, S. J. (2004). Organisms isolated from adults with cystic fibrosis. Ann Clin Microbiol Antimicrob 3, 26. (Pubitemid 44650231)
37. Michel-Briand, Y. & Baysse, C. (2002). The pyocins of Pseudomonas aeruginosa. Biochimie 84, 499-510.
38. Nakayama, K., Takashima, K., Ishihara, H., Shinomiya, T., Kageyama, M., Kanaya, S., Ohnishi, M., Murata, T., Mori, H. & Hayashi, T. (2000). The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol 38, 213-231.
39. Ohkawa, I., Shiga, S. & Kageyama, M. (1980). Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2. J Biochem 87, 323-331. (Pubitemid 10138346)
40. Pugsley, A. P. & Oudega, B. (1987). Methods for studying colicins and their plasmids. In Plasmids: a Practical Approach, pp. 105-161. Edited by K. G. Hardy. Oxford: IRL.
41. Riley, M. A. & Gordon, D. M. (1999). The ecological role of bacteriocins in bacterial competition. Trends Microbiol 7, 129-133.
42. Riley, M. A. & Wertz, J. E. (2002a). Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie 84, 357-364.
43. Riley, M. A. & Wertz, J. E. (2002b). Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56, 117-137.
44. Riley, M. A., Goldstone, C. M., Wertz, J. E. & Gordon, D. (2003). A phylogenetic approach to assessing the targets of microbial warfare. J Evol Biol 16, 690-697.
45. Sano, Y. & Kageyama, M. (1981). Purification and properties of an Stype pyocin, pyocin AP41. J Bacteriol 146, 733-739. (Pubitemid 11078261)
46. Sano, Y. & Kageyama, M. (1993). A novel transposon-like structure carries the genes for pyocin AP41, a Pseudomonas aeruginosa bacteriocin with a DNase domain homology to E2 group colicins. Mol Gen Genet 237, 161-170. (Pubitemid 23076489)
47. Sano, Y., Matsui, H., Kobayashi, M. & Kageyama, M. (1990). Pyocins S1 and S2, bacteriocins of Pseudomonas aeruginosa. In Pseudomonas: Biotransformations, Pathogenesis, and Evolving Biotechnology, pp. 352-358. Edited by S. Silver, A. M. Chakrabarty, B. Iglewski & S. Kaplan. Washington, DC: American Society for Microbiology.
48. Sano, Y., Kobayashi, M. & Kageyama, M. (1993a). Functional domains of S-type pyocins deduced from chimeric molecules. J Bacteriol 175, 6179-6185. (Pubitemid 23292431)
49. Sano, Y., Matsui, H., Kobayashi, M. & Kageyama, M. (1993b). Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa. J Bacteriol 175, 2907-2916. (Pubitemid 23148723)
50. Seed, K. D. & Dennis, J. J. (2005). Isolation and characterization of bacteriophages of the Burkholderia cepacia complex. FEMS Microbiol Lett 251, 273-280. (Pubitemid 41383879)
51. Seo, Y. & Galloway, D. R. (1990). Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity. Biochem Biophys Res Commun 172, 455-461. (Pubitemid 20384442)
52. Shinomiya, T., Shiga, S. & Kageyama, M. (1983). Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. I. Localization of the pyocin R2 gene cluster between the trpCD and trpE genes. Mol Gen Genet 189, 375-381.
53. Summer, E. J., Gonzalez, C. F., Carlisle, T., Mebane, L. M., Cass, A. M., Savva, C. G., LiPuma, J. & Young, R. (2004). Burkholderia cenocepacia phage BcepMu and a family of Mu-like phages encoding potential pathogenesis factors. J Mol Biol 340, 49-65. (Pubitemid 38739437)
54. Tablan, O. C., Chorba, T. L., Schidlow, D. V., White, J. W., Hardy, K. A., Gilligan, P. H., Morgan, W. M., Carson, L. A., Martone, W. J. & other authors (1985). Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 107, 382-387.
55. Waite, R. D. & Curtis, M. A. (2009). Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms. J Bacteriol 191, 1349-1354.
56. Weaver, V. B. & Kolter, R. (2004). Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol 186, 2376-2384.
57. Whiteford, M. L., Wilkinson, J. D., McColl, J. H., Conlon, F. M., Michie, J. R., Evans, T. J. & Paton, J. Y. (1995). Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50, 1194-1198.
58. Williams, S. R., Gebhart, D., Martin, D. W. & Scholl, D. (2008). Retargeting R-type pyocins to generate novel bactericidal protein complexes. Appl Environ Microbiol 74, 3868-3876. (Pubitemid 351874919)
59. Zabransky, R. J. & Day, F. E. (1969). Pyocine typing of clinical strains of Pseudomonas aeruginosa. Appl Microbiol 17, 293-296.
60. Zar, J. H. (1999). Biostatistical Analysis, 4th edn. Upper Saddle River, NJ: Prentice Hall.